Chen DM - Search Results

1

Reliability and validity of the Advanced Basal Cell Carcinoma Index (aBCCdex).

Mathias SD, Chren MM, Crosby RD, Colwell HH, Yim YM, Reyes C, Chen DM, Fosko SW. Mathias SD, et al. Among authors: chen dm. Br J Dermatol. 2015 Sep;173(3):713-9. doi: 10.1111/bjd.13877. Epub 2015 Jun 11. Br J Dermatol. 2015. PMID: 25939524

2

Age distribution of patients with advanced non-melanoma skin cancer in the United States.

Dacosta Byfield S, Chen D, Yim YM, Reyes C. Dacosta Byfield S, et al. Arch Dermatol Res. 2013 Nov;305(9):845-50. doi: 10.1007/s00403-013-1357-2. Epub 2013 Apr 21. Arch Dermatol Res. 2013. PMID: 23604961 Free PMC article.

3

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.

Chang AL, Solomon JA, Hainsworth JD, Goldberg L, McKenna E, Day BM, Chen DM, Weiss GJ. Chang AL, et al. Among authors: chen dm. J Am Acad Dermatol. 2014 Jan;70(1):60-9. doi: 10.1016/j.jaad.2013.09.012. Epub 2013 Nov 1. J Am Acad Dermatol. 2014. PMID: 24189279 Free article. Clinical Trial.

4

Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires.

Mathias SD, Chren MM, Colwell HH, Yim YM, Reyes C, Chen DM, Fosko SW. Mathias SD, et al. Among authors: chen dm. JAMA Dermatol. 2014 Feb;150(2):169-76. doi: 10.1001/jamadermatol.2013.5870. JAMA Dermatol. 2014. PMID: 24285085

5

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases. Chen DM, et al. Br J Dermatol. 2020 May;182(5):1111-1119. doi: 10.1111/bjd.18482. Epub 2019 Nov 28. Br J Dermatol. 2020. PMID: 31487383 Free PMC article. Clinical Trial.

6

A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.

Jacobson ME, Rick JW, Gerbens LAA, Baghoomian W, Gould LJ, Marzano AV, Chen DM, Oakes DL, Dissemond J, Yamamoto T, Shinkai K, Nolan B, Lobato D, Thomas KS, Ortega-Loayza AG; UPGRADE. Jacobson ME, et al. Among authors: chen dm. Br J Dermatol. 2024 Feb 16;190(3):392-401. doi: 10.1093/bjd/ljad420. Br J Dermatol. 2024. PMID: 37952167

7

Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.

Webster G, Thiboutot DM, Chen DM, Merikle E. Webster G, et al. Among authors: chen dm. Cutis. 2010 Nov;86(5):263-7. Cutis. 2010. PMID: 21214129 Clinical Trial.

8

Cumulative oral corticosteroid use increases risk of glucocorticoid-related adverse events in patients with newly diagnosed pemphigus.

Wormser D, Chen DM, Brunetta PG, Sun D, Broder MS, Chang E, Reddy SR. Wormser D, et al. Among authors: chen dm. J Am Acad Dermatol. 2017 Aug;77(2):379-381. doi: 10.1016/j.jaad.2017.04.1116. J Am Acad Dermatol. 2017. PMID: 28711092 Free article. No abstract available.

9

Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.

Piacquadio DJ, Chen DM, Farber HF, Fowler JF Jr, Glazer SD, Goodman JJ, Hruza LL, Jeffes EW, Ling MR, Phillips TJ, Rallis TM, Scher RK, Taylor CR, Weinstein GD. Piacquadio DJ, et al. Among authors: chen dm. Arch Dermatol. 2004 Jan;140(1):41-6. doi: 10.1001/archderm.140.1.41. Arch Dermatol. 2004. PMID: 14732659 Clinical Trial.

10

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.

Thiboutot D, Zaenglein A, Weiss J, Webster G, Calvarese B, Chen D. Thiboutot D, et al. J Am Acad Dermatol. 2008 Nov;59(5):792-800. doi: 10.1016/j.jaad.2008.06.040. Epub 2008 Sep 20. J Am Acad Dermatol. 2008. PMID: 18805603 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters